Current Pharmaceutical Biotechnology
Title:Editorial (Thematic Issue: Special Issue for Current Pharmaceutical Biotechnology Miniaturized Platforms & Methods for Pharmaceutical Studies)
Volume: 17 Issue: 9
Author(s): XiuJun (James) Li
Affiliation:
Export Options
About this article
Cite this article as:
Li (James) XiuJun, Editorial (Thematic Issue: Special Issue for Current Pharmaceutical Biotechnology Miniaturized Platforms & Methods for Pharmaceutical Studies), Current Pharmaceutical Biotechnology 2016; 17 (9) . https://dx.doi.org/10.2174/138920101709160606115045
DOI https://dx.doi.org/10.2174/138920101709160606115045 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effective Inhibition of Foam Cells Formation by Tanshinone IIA in RAW264.7 Macrophages Induced with LDL Isolated from Hypercholesterolemia Patients: A Proteomic Analysis
Current Proteomics Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review
Current Drug Targets Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart
Current Medicinal Chemistry Comparison of the Determinants of the Health Service System and the Health Status of the People in the Greater Mekong Subregion (GMS)
Current Psychiatry Reviews Role of Polymorphisms in Factor V (FV Leiden), Prothrombin, Plasminogen Activator Inhibitor Type-1 (PAI-1), Methylenetetrahydrofolate Reductase (MTHFR) and Cystathionine β-Synthase (CBS) Genes as Risk Factors for Thrombophilias
Mini-Reviews in Medicinal Chemistry Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Current Pharmaceutical Design The Role of White Matter Abnormalities in Treatment-Resistant Depression: A Systematic Review
Current Pharmaceutical Design The Potential Role of Morus Alba Leaves Extract on the Brain of Mice Infected with Schistosoma Mansoni
CNS & Neurological Disorders - Drug Targets Sympathetic and Baroreflex Function in Hypertension: Implications for Current and New Drugs
Current Pharmaceutical Design Recent Patents on Diacylglycerol Production and Applications
Recent Patents on Chemical Engineering Editorial (Hot Topics: New Insights in the Pathogenesis and Treatment of Diabetic Retinopathy)
Current Medicinal Chemistry Therapeutic Effects and Mechanisms of Action of Cyclosporine A Ophthalmic Solution in the Treatment of Vernal Keratoconjunctivitis
Current Pharmaceutical Analysis Revised Roberts Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator
Current Pharmaceutical Design Prevention of Ischemic Stroke: Overview of Traditional Risk Factors
Current Drug Targets Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials
CNS & Neurological Disorders - Drug Targets The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Current Pharmaceutical Design Influences of Maternal Nutritional Status on Vascular Function in the Offspring
Current Drug Targets Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
Current Cardiology Reviews Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry